Alpha Tau to Present at Upcoming November Investor Conferences
November 09 2022 - 8:00AM
Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau", or the
“Company”), the developer of the innovative alpha-radiation cancer
therapy Alpha DaRT™, today announced the Company will present in
person at the following investor conferences in November:
Event: |
Jefferies London Healthcare Conference |
Date & Time: |
Wednesday, November 16, 2022 at
4:25pm GMT |
Location: |
London, UK |
Event: |
Piper Sandler 34th Annual Healthcare Conference |
Date & Time: |
Wednesday, November 30, 2022 at
1:30pm EST |
Location: |
New York, NY |
Additional information can be found on the
Events and Presentations section of Alpha Tau’s investor website,
at www.alphatau.com/events. If you would like to schedule a 1:1
meeting, please contact the appropriate institutional
representative.
About Alpha DaRT™
Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is
designed to enable highly potent and conformal alpha-irradiation of
solid tumors by intratumoral delivery of radium-224 impregnated
sources. When the radium decays, its short-lived daughters are
released from the sources and disperse while emitting high-energy
alpha particles with the goal of destroying the tumor. Since the
alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims
to mainly affect the tumor, and to spare the healthy tissue around
it.
About Alpha Tau Medical Ltd.
Founded in 2016, Alpha Tau is an Israeli medical device company
that focuses on research, development, and potential
commercialization of the Alpha DaRT for the treatment of solid
tumors. The technology was initially developed by Prof. Itzhak
Kelson and Prof. Yona Keisari from Tel Aviv University.
Investor Relations Contact
IR@alphatau.com
Alpha Tau Medical (NASDAQ:DRTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Alpha Tau Medical (NASDAQ:DRTS)
Historical Stock Chart
From Jul 2023 to Jul 2024